(19)
(11) EP 1 418 869 A1

(12)

(43) Date of publication:
19.05.2004 Bulletin 2004/21

(21) Application number: 02736750.7

(22) Date of filing: 13.05.2002
(51) International Patent Classification (IPC)7A61F 13/00, A61K 9/70
(86) International application number:
PCT/US2002/014930
(87) International publication number:
WO 2002/091966 (21.11.2002 Gazette 2002/47)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 11.05.2001 US 853304
30.11.2001 US 10201
22.01.2002 US 351167 P

(71) Applicant: Kava Pharmaceuticals, Inc.
Boston, MA 02109 (US)

(72) Inventors:
  • MCCLEARY, Joel
    The Plains, VA 20198 (US)
  • SUN, Lijun
    Harvard, MA 01451 (US)
  • STAATS, Peter, S.
    Towson, MA 22186 (US)
  • CHEN, Shoujun
    Bedford, MA 01730 (US)

(74) Representative: Harrison Goddard Foote 
Fountain Precinct,Leopold Street
Sheffield S1 2QD
Sheffield S1 2QD (GB)

   


(54) KAVALACTONE COMPOSITIONS AND METHODS OF USE